Reactivation of Epstein-Barr virus can be triggered by an Rta protein mutated at the nuclear localization signal.

Rta, an immediate-early protein of Epstein-Barr virus (EBV), is a transcriptional activator that induces lytic gene expression and triggers virus reactivation. Being located predominantly in the nucleus, Rta can exert its transactivation function through either direct DNA binding or certain indirect mechanisms mediated by cellular signalling and other transcriptional factors. This study examined whether the subcellular localization of Rta was critical for the induction of target genes. First, 410KRKK413 was identified as a nuclear localization signal (NLS) of Rta. An Rta mutant with the NLS converted to 410AAAA413 showed cytoplasmic localization and failed to activate the promoter of BGLF5. Interestingly, ectopic expression of the Rta mutant still disrupted EBV latency in an epithelial cell line. Reporter gene assays revealed that the NLS-mutated Rta retained the ability to activate two lytic promoters, Zp and Rp, at a considerable level. Thus, the cytoplasmic Rta mutant could induce expression of endogenous Zta and Rta, triggering reactivation of EBV.

[1]  Shih-Shin Chang,et al.  Inhibition of the Epstein-Barr virus lytic cycle by Zta-targeted RNA interference. , 2004, The Journal of general virology.

[2]  S. Speck,et al.  Synergistic autoactivation of the Epstein-Barr virus immediate-early BRLF1 promoter by Rta and Zta. , 2003, Virology.

[3]  S. Kenney,et al.  Epstein-Barr Virus Immediate-Early Protein BRLF1 Induces the Lytic Form of Viral Replication through a Mechanism Involving Phosphatidylinositol-3 Kinase Activation , 2001, Journal of Virology.

[4]  Autostimulation of the Epstein-Barr Virus BRLF1 Promoter Is Mediated through Consensus Sp1 and Sp3 Binding Sites , 2001, Journal of Virology.

[5]  S. T. Liu,et al.  Activation of the BRLF1 promoter and lytic cycle of Epstein-Barr virus by histone acetylation. , 2000, Nucleic acids research.

[6]  W. Hammerschmidt,et al.  The Epstein–Barr virus lytic program is controlled by the co‐operative functions of two transactivators , 2000, The EMBO journal.

[7]  S. Kenney,et al.  Epstein-Barr Virus Immediate-Early Proteins BZLF1 and BRLF1 Activate the ATF2 Transcription Factor by Increasing the Levels of Phosphorylated p38 and c-Jun N-Terminal Kinases , 2000, Journal of Virology.

[8]  S. T. Liu,et al.  Characterization of the Epstein-Barr virus BALF2 promoter. , 1999, The Journal of general virology.

[9]  Ching‐Hwa Tsai,et al.  Requirement for Cell-to-Cell Contact in Epstein-Barr Virus Infection of Nasopharyngeal Carcinoma Cells and Keratinocytes , 1999, Journal of Virology.

[10]  T. Ragoczy,et al.  The Epstein-Barr Virus Rta Protein Activates Lytic Cycle Genes and Can Disrupt Latency in B Lymphocytes , 1998, Journal of Virology.

[11]  Ching‐Hwa Tsai,et al.  Characterization of Monoclonal Antibodies to the Zta and DNase Proteins of Epstein-Barr Virus. , 1997, Journal of biomedical science.

[12]  S. Kenney,et al.  Epstein-Barr viral latency is disrupted by the immediate-early BRLF1 protein through a cell-specific mechanism. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[13]  J. Pagano,et al.  Activation of the Epstein-Barr virus DNA polymerase promoter by the BRLF1 immediate-early protein is mediated through USF and E2F , 1996, Journal of virology.

[14]  E. Kieff Epstein-Barr virus and its replication , 1996 .

[15]  H. Gruffat,et al.  Characterization of the DNA-binding site repertoire for the Epstein-Barr virus transcription factor R. , 1994, Nucleic acids research.

[16]  D. Gutsch,et al.  Direct BRLF1 binding is required for cooperative BZLF1/BRLF1 activation of the Epstein-Barr virus early promoter, BMRF1. , 1993, Nucleic acids research.

[17]  J M Hardwick,et al.  The Epstein-Barr virus R transactivator (Rta) contains a complex, potent activation domain with properties different from those of VP16 , 1992, Journal of virology.

[18]  R. Buckland,et al.  Characterization of an R-binding site mediating the R-induced activation of the Epstein-Barr virus BMLF1 promoter , 1992, Journal of virology.

[19]  C. Tsai,et al.  Characterization of two monoclonal antibodies to Epstein-Barr virus diffuse early antigen which react to two different epitopes and have different biological function. , 1991, Journal of virological methods.

[20]  J. Giot,et al.  Domains of the Epstein-Barr virus (EBV) transcription factor R required for dimerization, DNA binding and activation. , 1991, Nucleic acids research.

[21]  P. Farrell,et al.  Pathways of activation of the Epstein-Barr virus productive cycle , 1991, Journal of virology.

[22]  S. Kenney,et al.  The Epstein-Barr virus (EBV) BMRF1 promoter for early antigen (EA-D) is regulated by the EBV transactivators, BRLF1 and BZLF1, in a cell-specific manner , 1990, Journal of virology.

[23]  E. Flemington,et al.  Autoregulation of Epstein-Barr virus putative lytic switch gene BZLF1 , 1990, Journal of virology.

[24]  J. Hardwick,et al.  An enhancer within the divergent promoter of Epstein-Barr virus responds synergistically to the R and Z transactivators , 1990, Journal of virology.

[25]  S. Kenney,et al.  The Epstein-Barr virus BMLF1 promoter contains an enhancer element that is responsive to the BZLF1 and BRLF1 transactivators , 1989, Journal of virology.

[26]  L. Heston,et al.  Transfection of a rearranged viral DNA fragment, WZhet, stably converts latent Epstein-Barr viral infection to productive infection in lymphoid cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[27]  William D. Richardson,et al.  A short amino acid sequence able to specify nuclear location , 1984, Cell.